| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 04/25/2006 | US7033761 aspirating solution into dispensers comprising pipette tips connected to syringe pump, pressurizing, then applying electromechanical force to spot droplets; for tissue-targeted diagnosis/therapy |
| 04/25/2006 | US7033760 Metallic solid supports modified with nucleic acids |
| 04/25/2006 | US7033759 Allelic opiate membrane protein for determining susceptibility of individuals to addictive diseases; monitoring response to analgesics and learning enhancement agents |
| 04/25/2006 | US7033758 Detecting preferential nucleotide sequences in samples; obtain tissue, samples, incubate with oligonucleotide probes, wash, detect signal from probes |
| 04/25/2006 | US7033757 Detecting mutation in sample; obtain nucleotide sequences, incubate with primer, hybridize, cleave nucleotide sequences, remove segments, detect mutation |
| 04/25/2006 | US7033756 detection of gene overexpression by binding transcription factor sites |
| 04/25/2006 | US7033755 Diagnostics and therapeutics for glaucoma |
| 04/25/2006 | US7033754 comprises identifier binding ligands; solid phase synthesis |
| 04/25/2006 | US7033753 Compositions and methods for nonenzymatic ligation of oligonucleotides and detection of genetic polymorphisms |
| 04/25/2006 | US7033752 Spinal muscular atrophy diagnostic methods |
| 04/25/2006 | US7033751 Comprises viral glycoprotein fusion with glutathione s-tranferase (GST) or thioredoxin for use as diagnostic tool in screening blood products for retroviral infection |
| 04/25/2006 | US7033750 Recombinant P53 adenovirus methods and compositions |
| 04/25/2006 | US7033749 Detection of preferential nucleotidse sequences; obtain sample, incubate with probe, detect signal, recover nucleotide sequences |
| 04/25/2006 | US7033748 Detection of prefrential microorganisms in sample, obtain cells, culture, propagate detect expression of bacterial prteins, the presence of bacterial protein indnicates infection |
| 04/25/2006 | US7033747 Apparatus for use in the detection of preferential targets in sample |
| 04/25/2006 | US7033746 For carcinoma detection and therapy |
| 04/25/2006 | US7033745 Use of gluclose-6-phosphate isomerase and antibodies thereto for the diagnosis and therapy of arthritis, and test of anti-arthritic compounds |
| 04/25/2006 | US7033596 Transformant for screening of inhibitors for human immunodeficiency virus |
| 04/25/2006 | CA2408348C Mixed cell systems for the detection of viruses |
| 04/25/2006 | CA2353520C Animal model for psoriasis for the prevention and treatment of psoriasis in humans |
| 04/22/2006 | CA2517203A1 Method for evaluation of endocrine disruptive action |
| 04/20/2006 | WO2006042328A2 Treatment of cancer and compositions |
| 04/20/2006 | WO2006042304A1 Concentration determination in a diffusion barrier layer |
| 04/20/2006 | WO2006042281A2 Method for diagnosing tuberous sclerosis complex |
| 04/20/2006 | WO2006042237A2 B7-h1 and methods of diagnosis, prognosis, and treatment of cancer |
| 04/20/2006 | WO2006042158A2 Methods and compositions for improving recombinant protein production |
| 04/20/2006 | WO2006042137A2 Methods for identifying parkinson's disease therapeutics |
| 04/20/2006 | WO2006042136A2 Detection of nucleic acids to assess risk for creutzfeldt-jakob disease |
| 04/20/2006 | WO2006042035A2 Method of monitoring anti-tumor activity of an hdac inhibitor |
| 04/20/2006 | WO2006042005A2 Global gene expression profiling of circulating tumor cells |
| 04/20/2006 | WO2006041938A2 Micropatterned plate with micro-pallets for addressable biochemical analysis |
| 04/20/2006 | WO2006041933A2 Improved vaccines |
| 04/20/2006 | WO2006041844A2 Assay for cytochrome p450 isoform 2c9 |
| 04/20/2006 | WO2006041745A2 Two-color chemiluminescent microarray system |
| 04/20/2006 | WO2006041617A1 Biodegradable cationic polymers |
| 04/20/2006 | WO2006041535A2 Capillary lithography of nanofiber arrays |
| 04/20/2006 | WO2006041524A2 Nucleic acid detection system |
| 04/20/2006 | WO2006041472A2 Enzyme-based device for environmental monitoring |
| 04/20/2006 | WO2006041392A1 Preparation and use of a reactive solid support surface |
| 04/20/2006 | WO2006041194A1 LINKER FOR CONSTRUCTING mRNA-PUROMYCIN-PROTEIN CONJUGATE |
| 04/20/2006 | WO2006041159A1 Primer having promoter region added thereto |
| 04/20/2006 | WO2006041130A1 Gel for zymography |
| 04/20/2006 | WO2006041036A1 Method of presuming or judging the efficacy of antitumor effect of epidermal growth factor receptor tyrosine kinase inhibitor |
| 04/20/2006 | WO2006040920A1 Method of evaluating ctl induction ability and screening method using the same |
| 04/20/2006 | WO2006040553A1 Sequencing a polymer molecule |
| 04/20/2006 | WO2006040551A2 Compartmentalised screening by microfluidic control |
| 04/20/2006 | WO2006040550A1 Identifying a target polynucleotide |
| 04/20/2006 | WO2006040549A2 Labelling and sequencing of nucleic acids |
| 04/20/2006 | WO2006040481A2 Method for diagnosing and treating crohn's disease |
| 04/20/2006 | WO2006040448A1 Universal primers and their use for detecting and identifying plant materials in complex mixtures |
| 04/20/2006 | WO2006040409A1 Method and kit for detecting a risk of acute myocardial infarction |
| 04/20/2006 | WO2006040356A1 Method for the preparation of a biological identifier |
| 04/20/2006 | WO2006040172A1 Thermostable mutants of pyrroloquinoline quinone dependent glucose dehydrogenase |
| 04/20/2006 | WO2006040161A1 Identification and assignment of functionally corresponding regulatory sequences for orthologous loci in eukaryotic genomes |
| 04/20/2006 | WO2006040104A2 Sequencing of nucleic acids with strand displacement |
| 04/20/2006 | WO2006040047A2 Diagnostics and therapeutics for diseases associated with rho/rac-interacting citron kinase (cit) |
| 04/20/2006 | WO2006039792A1 Method of treating autoimmune diseases |
| 04/20/2006 | WO2006034370A3 Systems and methods for evaluating enzyme competency |
| 04/20/2006 | WO2006023312A3 Diagnostic assay for source of inflammation |
| 04/20/2006 | WO2006021888A3 Dihydrofolate reductase inhibition by epigallocatechin gallate compounds |
| 04/20/2006 | WO2006021673A3 Markers and methods for prenatal screening of chromosomal aberrations |
| 04/20/2006 | WO2006018311A3 Determination of nucleic acid analytes by treatment with microwaves |
| 04/20/2006 | WO2006016392A3 Complex able to detect an analyte, method for its preparation and uses thereof |
| 04/20/2006 | WO2006014903A3 Compositions and methods of use for adam12 antagonists in treating disease |
| 04/20/2006 | WO2006005636A9 Microfluidic device for performing a plurality of reactions and uses thereof |
| 04/20/2006 | WO2006002100A3 Diagnostic and screening methods and kits associated with proteolytic activity |
| 04/20/2006 | WO2005117859A3 Methods of diagnosing cardiovascular disease |
| 04/20/2006 | WO2005113802A3 Genotoxic testing |
| 04/20/2006 | WO2005113789A3 Method for identifying compounds that have the ability to inhibit the activity of myc |
| 04/20/2006 | WO2005098030A3 Method for the identification of fungicidally-effective compounds based on thioredoxin reductases |
| 04/20/2006 | WO2005089315A3 Methods and compositions related to skcg-1, a tumor suppressor gene |
| 04/20/2006 | WO2005084223A8 Methods and compositions for hair growth |
| 04/20/2006 | WO2005084109A3 Cancer specific gene mh15 |
| 04/20/2006 | WO2005073410A3 Nucleic acid amplification with continuous flow emulsion |
| 04/20/2006 | WO2005071117A3 Primer and probe design for efficient amplification and detection of hcv 3′ non-translating region |
| 04/20/2006 | WO2005066371A3 Methods for predicting and overcoming resistance to chemotherapy in ovarian cancer and for predicting colon cancer occurrence |
| 04/20/2006 | WO2005059108A3 Gene expression profiles and methods of use |
| 04/20/2006 | WO2005049832A3 FcϜRIIA-SPECIFIC NUCLEIC ACID INTERFERENCE |
| 04/20/2006 | WO2005048818A3 Methods of diagnosing renal disease |
| 04/20/2006 | WO2005046606A3 Compositions and methods for diagnosing and treating chronic lymphocytic leukemia |
| 04/20/2006 | WO2005040751A3 Decontamination and concentration kit for mycobacteria |
| 04/20/2006 | WO2005035785A3 Method for the rapid detection of micro-organisms on dna chips |
| 04/20/2006 | WO2005034840A8 Identification of kinase inhibitors |
| 04/20/2006 | WO2005019423A3 Methods and compositions comprising fatp5 for use in the diagnosis and treatment of metabolic disorders |
| 04/20/2006 | WO2004097027A3 Screening of biocatalysts in plants |
| 04/20/2006 | WO2004051222A3 Methods for the identification of agents for the treatment of seizures, neurological diseases, endocrinopathies and hormonal diseases |
| 04/20/2006 | WO2004044164A3 Method for identifying risk of melanoma and treatments thereof |
| 04/20/2006 | WO2004044011A3 Combinatorial libraries of monomer domains |
| 04/20/2006 | WO2003066871A3 Compositions and methods for altering biosynthesis of taxanes and taxane-related compounds |
| 04/20/2006 | US20060085139 System, method, and computer program product for extraction, gathering, manipulation, and analysis of peak data from an automated sequencer |
| 04/20/2006 | US20060084797 High affinity TGFbeta nucleic acid ligands and inhibitors |
| 04/20/2006 | US20060084791 Purified polypeptide, isolated nucleic acids encoding said polypeptide, vectors and use thereof |
| 04/20/2006 | US20060084790 P-Rex1, a ptdins (3,4,5) p3-g-beta-gamma-regulated guanine-nucleotide exchange factor for rac |
| 04/20/2006 | US20060084618 Adiponectin promoter and use thereof |
| 04/20/2006 | US20060084600 Human homologues of fused gene |
| 04/20/2006 | US20060084595 Complex comprising OCIF and polysaccharide |
| 04/20/2006 | US20060084144 Genetic engineering; oligonucleotide detector; identification and isolation of novel DNA; transmembrane domain-deleted or transmembrane domain-inactivated protein; soluble extracellular domains; PRO polypeptide |
| 04/20/2006 | US20060084143 Screen for agonists and antagonists; treat solid tumors, vascular deficiencies; polypeptide, polynucleotide, plasmid; chemotherapeutic agents, alkylating agents, antimetabolites, vinca alkaloids, plant extracts, nitrosoureas, topoisomerase inhibitors, platinum analogs, adrenocortical suppressants |
| 04/20/2006 | US20060084139 Genetic engineering; oligonucleotide detector; identification and isolation of novel DNA; transmembrane domain-deleted or transmembrane domain-inactivated protein; soluble extracellular domains; PRO polypeptide |
| 04/20/2006 | US20060084138 Genetic engineering; oligonucleotide detector; identification and isolation of novel DNA; transmembrane domain-deleted or transmembrane domain-inactivated protein; soluble extracellular domains; PRO polypeptide |